Tirzepatide is an FDA-approved injectable medication used for type 2 diabetes. It has been indicated by the FDA for both weight loss in diabetics as well as in patients with obesity without a history of diabetes.
Tirzepatide mimics the Glucagon-like peptide-1 (GLP-1) and Glucose-dependent insulinotropic peptide (GIP) hormones, which are released by the intestines when you eat. They play a crucial role in regulating your appetite and blood sugar level. However, in the case of patients with diabetes or obesity, the production or function of these hormones may be impaired.
Tirzepatide emulates the actions of GLP-1 and GIP hormones and helps regulate insulin secretion after a meal. Therefore, it can help reduce insulin resistance and improve metabolic health.
Additionally, Tirzepatide slows down gastric emptying, which means that food stays in the stomach longer, making you feel full for a longer period and signaling fullness to the brain.
Tirzepatide's powerful effects on the brain, gut, and liver can also contribute significantly to its ability to promote the loss of unhealthy weight.
Like Semaglutide, Tirzepatide helps reduce food cravings and works best when combined with a balanced diet (rich in protein) and exercise. Tirzepatide can also help reduce your risk of cancer, diabetes, and heart disease.